Print Friendly Page
Protocol No. OS12601
Principal Investigator Albertini, Mark
Age Group Adult
Sponsor Type Institutional
Title T Cell Mutants as BioMarkers in Human Melanoma
Objective We are trying to increase our understanding of both human melanoma and human vitiligo so that better monitoring and treatment can be developed for patients with melanoma.
Description You are invited to participate in a research program by donating blood for experimental purposes. Your blood will be used in laboratory experiments to study subjects with melanoma and/or subjects with vitiligo. This study also studies advanced melanoma patients before and after treatment with Ipilimumab, a new treatment for that disease.
Metastatic melanoma patients (10 need to be before and after treatment with Ipilimumab).
Established diagnosis of vitiligo, with or without a current diagnosis of melanoma.
Normal control blood donors without a known diagnosis of melanoma or vitiligo.
Applicable Disease Sites Melanoma/Skin cancer
Participating Institutions UW Hospital and Clinics